Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Harris

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Oncotarget|August 30, 2023
Analytic validation of NeXT Dx™, a comprehensive genomic profiling assayJuan-Sebastian Saldivar, Jason Harris, Erin Ayash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or MutationsGang G Li, Romel Somwar, James Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2021
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance MechanismsCharles W Abbott, Sean M Boyle, Rachel Marty Pyke, et al.
Genome Medicine|August 14, 2015
Achieving high-sensitivity for clinical applications using augmented exome sequencingAnil Patwardhan, Jason Harris, Nan Leng, et al.
Vaccine|July 4, 2021
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in ZambiaJohn Mwaba, Caroline Cleopatra Chisenga, Shaoming Xiao, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell HemoglobinBrian Metcalf, Chihyuan Chuang, Kobina Dufu, et al.
Molecular Cancer Therapeutics|March 5, 2016
Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer IndicationsElena Ardini, Maria Menichincheri, Patrizia Banfi, et al.
Oncotarget|March 14, 2024
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assayJosette Northcott, Gabor Bartha, Jason Harris, et al.
Oncotarget|June 20, 2024
Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assayJosette Northcott, Gabor Bartha, Jason Harris, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2016
Early somatic mosaicism is a rare cause of long-QT syndromeJames Rush Priest, Charles Gawad, Kristopher M Kahlig, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Oncotarget|August 30, 2023
Analytic validation of NeXT Dx™, a comprehensive genomic profiling assayJuan-Sebastian Saldivar, Jason Harris, Erin Ayash, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or MutationsGang G Li, Romel Somwar, James Joseph, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2021
Prediction of Immunotherapy Response in Melanoma through Combined Modeling of Neoantigen Burden and Immune-Related Resistance MechanismsCharles W Abbott, Sean M Boyle, Rachel Marty Pyke, et al.
Genome Medicine|August 14, 2015
Achieving high-sensitivity for clinical applications using augmented exome sequencingAnil Patwardhan, Jason Harris, Nan Leng, et al.
Vaccine|July 4, 2021
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in ZambiaJohn Mwaba, Caroline Cleopatra Chisenga, Shaoming Xiao, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell HemoglobinBrian Metcalf, Chihyuan Chuang, Kobina Dufu, et al.
Molecular Cancer Therapeutics|March 5, 2016
Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer IndicationsElena Ardini, Maria Menichincheri, Patrizia Banfi, et al.
Oncotarget|March 14, 2024
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assayJosette Northcott, Gabor Bartha, Jason Harris, et al.
Oncotarget|June 20, 2024
Correction: Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assayJosette Northcott, Gabor Bartha, Jason Harris, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2016
Early somatic mosaicism is a rare cause of long-QT syndromeJames Rush Priest, Charles Gawad, Kristopher M Kahlig, et al.
Pageof 5